BNET Industries

SIGA Technologies Inc.

(SIGA) is in the Pharma Industry

Market Cap:$253.3M
Last Fiscal Year Sales:$8.0M
  • Public
  • US
Dow Jones Description

Since our inception in December 1995, SIGA has pursued the research, development and commercialization of novel products for the prevention and treatment of serious infectious diseases, including products for use in the defense against biological warfare agents such as smallpox and Arenaviruses. Our lead product, ST-246 ® , is an orally administered antiviral drug that targets orthopox viruses. In December 2005, the U.S. Food and Drug Administration (the "FDA") accepted our Investigational New Drug ("IND") application for ST-246 ® and granted the program "Fast-Track" status. In December 2006, the FDA granted Orphan Drug designation to ST-246 ® for the prevention and treatment of smallpox. In May 2009, we submitted a response to a Request for Proposal ("RFP") issued by the U.S. Biomedical Research and Development Agency ("BARDA") with respect to the purchase of 1.7 million courses of a smallpox antiviral (the " BARDA Smallpox RFP " ), and, in June 2009, BARDA informed us that our response to the BARDA Smallpox RFP was deemed technically acceptable and in the competitive range. There can be no assurance that SIGA or any other company will receive an award pursuant to this RFP. Further, any award on this RFP would be subject to negotiation of final contract terms and specifications; thus, the final terms under any contract with BARDA may be materially different than those indicated in this RFP. ...

Number of Employees 43
Contact Information

420 Lexington Ave Ste 408

New York, New York 10170-0699

siga.com

(212) 672-9100

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

Recent Events

  • SIGA Technologies raises $20 million through private placement

    12/15/09 - New Investment - View Story

  • SIGA Technologies Reports Operating Results for the Third Quarter of 2009

    11/09/09 - Financial Announcement - View Story

  • $1.6 Million NIH Cooperative Agreement Supports SIGA Broad Spectrum Antiviral Research

    9/29/09 - Joint Venture / Alliance - View Story

News & Analysis

healthcare and siga technologies inc. - All News and Analysis

advertisement
     SIGA $5.95 -0.06 (-1.00% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 632,299
Shares Outstanding 38.32M
Market Cap 228.0M
Year High 10.09
Year Low 2.7442
Earnings Per Share -0.56
P/E Ratio -10.62
Dividend N/A
Yield N/A
IndustryTop Rated

Brought to you by CBS MoneyWatch.com

advertisement
Click Here
Presented by American Express